Literature DB >> 18658127

Haloperidol versus chlorpromazine for treatment of schizophrenia.

C Leucht1, M Kitzmantel, L Chua, J Kane, S Leucht.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18658127      PMCID： PMC2632477          DOI： 10.1093/schbul/sbn087

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  5 in total

1.  A meta-analysis of the efficacy of second-generation antipsychotics.

Authors:  John M Davis; Nancy Chen; Ira D Glick
Journal:  Arch Gen Psychiatry       Date:  2003-06

2.  Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

Authors:  Peter B Jones; Thomas R E Barnes; Linda Davies; Graham Dunn; Helen Lloyd; Karen P Hayhurst; Robin M Murray; Alison Markwick; Shôn W Lewis
Journal:  Arch Gen Psychiatry       Date:  2006-10

3.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Authors:  Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao
Journal:  N Engl J Med       Date:  2005-09-19       Impact factor: 91.245

Review 4.  Haloperidol versus placebo for schizophrenia.

Authors:  C B Joy; C E Adams; S M Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

Review 5.  Chlorpromazine versus placebo for schizophrenia.

Authors:  C E Adams; G Awad; J Rathbone; B Thornley
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18
  5 in total
  5 in total

1.  Real-world Performance of Meta-analysis Methods for Double-Zero-Event Studies with Dichotomous Outcomes Using the Cochrane Database of Systematic Reviews.

Authors:  Yanan Ren; Lifeng Lin; Qinshu Lian; Hui Zou; Haitao Chu
Journal:  J Gen Intern Med       Date:  2019-03-18       Impact factor: 5.128

Review 2.  Ziprasidone versus other atypical antipsychotics for schizophrenia.

Authors:  Katja Komossa; Christine Rummel-Kluge; Heike Hunger; Sandra Schwarz; Paranthaman Seth S Bhoopathi; Werner Kissling; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

Review 3.  Crimean-Congo haemorrhagic fever virus: Past, present and future insights for animal modelling and medical countermeasures.

Authors:  E J Mendoza; B Warner; D Safronetz; C Ranadheera
Journal:  Zoonoses Public Health       Date:  2018-04-20       Impact factor: 2.702

Review 4.  Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future.

Authors:  Peng Li; Gretchen L Snyder; Kimberly E Vanover
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

5.  Pharmacological Treatment for Long-Term Patients with Schizophrenia and Its Effects on Sleep in Daily Clinical Practice: A Pilot Study.

Authors:  Peggy Bosch; Sabina Lim; Heike Staudte; Sujung Yeo; Sook-Hyun Lee; Pia Barisch; Benoît Perriard; Maurits Van den Noort
Journal:  Medicines (Basel)       Date:  2018-05-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.